Alembic Pharmaceuticals Ltd.
| BSE: 533573 | Sector: Health care |
| NSE: APLLTD | ISIN Code: INE901L01018 |
| BSE LIVE 15:40 | 27 Jun | 496.05 |
-11.70 (-2.30%) |
OPEN
512.30 |
HIGH
516.85 |
LOW
492.25 |
| NSE 15:31 | 27 Jun | 504.25 |
-7.65 (-1.49%) |
OPEN
512.10 |
HIGH
518.00 |
LOW
498.10 |
| OPEN | 512.30 |
| PREVIOUS CLOSE | 507.75 |
| VOLUME | 28025 |
| 52-Week high | 709.30 |
| 52-Week low | 492.25 |
| P/E | 22.52 |
| Mkt Cap.(Rs cr) | 9,351 |
| Buy Price | 496.05 |
| Buy Qty | 1205.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Alembic Pharmaceuticals Ltd. (APLLTD) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Lupin | 1063.35 | 2.50 | 0.24 | 2885.07 |
| Cadila Health. | 525.50 | 0.40 | 0.08 | 1977.30 |
| Torrent Pharma. | 1183.40 | 5.80 | 0.49 | 1763.34 |
| Aurobindo Pharma | 670.30 | -1.05 | -0.16 | 1619.67 |
| Glenmark Pharma. | 629.60 | 2.15 | 0.34 | 1468.43 |
| Cipla | 534.35 | -6.50 | -1.20 | 1398.03 |
| Dr Reddy's Labs | 2654.25 | 11.75 | 0.44 | 1354.50 |
| Divi's Lab. | 642.20 | 3.75 | 0.59 | 1107.69 |
| Piramal Enterp. | 2805.35 | -15.25 | -0.54 | 1061.15 |
| Biocon | 323.05 | -6.65 | -2.02 | 808.80 |
| Alkem Lab | 1819.70 | -5.45 | -0.30 | 638.44 |
| Ajanta Pharma | 1517.35 | 4.95 | 0.33 | 499.81 |
| Alembic Pharma | 496.05 | -11.70 | -2.30 | 430.63 |
| Apollo Hospitals | 1273.20 | -6.40 | -0.50 | 369.44 |
| Glaxosmit Pharma | 2465.65 | 0.90 | 0.04 | 336.78 |
| Sanofi India | 4137.75 | -15.70 | -0.38 | 297.00 |
| Abbott India | 4238.95 | -77.10 | -1.79 | 276.65 |
| Pfizer | 1782.30 | 8.70 | 0.49 | 222.77 |
| Syngene Intl. | 456.35 | -2.25 | -0.49 | 221.20 |
| Laurus Labs | 612.10 | 5.05 | 0.83 | 202.57 |
Quick Links for Alembic Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
